Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Metabolic Syndrome 1Lymphoma, Non-Hodgkin 1Heart Failure 1Dyslipidemias 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Pulse Wave Analysis × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

NCT05641636 2022-12-07

Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors

I.M. Sechenov First Moscow State Medical University

Completed
60 enrolled
CNS

Central Nervous System Neoplasms, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡